{
  "ticker": "REGN",
  "last_updated": "2025-04-19T08:33:46.038115",
  "retention_years": 3,
  "count": 409,
  "transactions": [
    {
      "id": 164790,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 164796,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 136677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 164821,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 136664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 136671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 164808,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 164815,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 136663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 164807,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 110503,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 110551,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136653,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 136705,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164797,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 164849,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110533,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 110542,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 136687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 136696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 164831,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 164840,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110529,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 136683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 164827,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 110530,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 136684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 164828,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 110506,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 110508,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136656,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 136658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164800,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 164802,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110495,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 110509,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 110526,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 136645,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 136659,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 136680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 164787,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 164803,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 164824,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 110536,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 136690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 164834,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 86280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 110505,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 110541,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 136655,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 136695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 164799,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 164839,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 64349,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 64356,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 86307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 86315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110539,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 110548,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 136702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164837,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 164846,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 64318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 86274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 110498,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 136648,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 164791,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 64342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 86299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 110528,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 136682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 164826,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 64321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64359,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110501,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110552,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136651,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136706,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164794,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164850,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 86276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 110500,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 136650,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 164793,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 64338,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 86295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 110523,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 136676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 164820,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 64330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 64348,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 86287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 86306,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 110515,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 110538,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 136667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 136692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 164811,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 164836,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 64334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 86291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 110519,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 136672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 164816,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 44627,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 64344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 86301,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 110532,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 136686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 164830,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 44632,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 64351,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 86310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 110543,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 136697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 164841,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 44615,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 64328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 86285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 110513,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 136665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 164809,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 44611,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 64324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 86281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 110507,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 136657,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 164801,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 44636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 64355,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 86314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 110547,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 136701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 164845,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 44609,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 64322,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 86278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 110502,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 136652,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 164795,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 44631,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 44635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 64350,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 64354,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 86308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 86313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 110540,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 110546,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 136694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 136700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 164838,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 164844,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 44628,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110534,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164832,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 27642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 27658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 44613,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 44634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 64326,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 64353,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 86283,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 86312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 110511,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 110545,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 136661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 136699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 164805,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 164843,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 14702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 27659,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 44637,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 64357,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 86316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110549,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 136703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 164847,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 14691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 14698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 27647,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 27654,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 44619,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 44626,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 64333,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 64343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 86290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 86300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 110518,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 110531,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 136670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 136685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 164814,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 164829,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 14681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 14682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 14683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 14688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 27636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 27637,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 27638,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 27644,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 44604,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 44605,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 44606,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 44616,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 64314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 64315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 64316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 64329,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 86270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 86271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 86272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 86286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 110493,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 110494,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 110496,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 110514,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 136643,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 136644,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 136646,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 136666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 164785,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 164786,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 164788,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 164810,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 14690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 27641,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 27646,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 44612,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 44618,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 64325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 64332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 86282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 86289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 110510,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 110517,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 136660,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 136669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 164804,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 164813,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 4668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 14693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 27649,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 44621,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 64336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 86293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 110521,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 136674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 164818,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 4666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 14689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 27645,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 44617,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 64331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 86288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 110516,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 136668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 164812,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 4671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 4675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 14696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 14701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 27652,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 27657,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 44624,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 44633,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 64340,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 64352,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 86297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 86311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 110525,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 110544,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 136679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 136698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 164823,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 164842,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 4676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 27660,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 44638,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 64358,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 86317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 110550,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 136704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 164848,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 4670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 4677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 14695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 14704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 27651,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 27661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 44623,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 44639,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 64339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 64360,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 86296,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 86319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 110524,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 110553,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 136678,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 136707,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 164822,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 164851,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 4662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 14680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 27635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 44603,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 64313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 86269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 110492,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 136642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 164784,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 4664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 4669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 14685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 14694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 27640,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 27650,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 44608,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 44622,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 64319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 64337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 86275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 86294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 110499,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 110522,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 136649,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 136675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 164792,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 164819,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 4661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 4663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 14679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 14684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 27634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 27639,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 44602,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 44607,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 64312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 64317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 86268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 86273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 110491,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 110497,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 136641,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 136647,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 164783,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 164789,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 4674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 14700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 27656,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 44630,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 64347,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 86305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 110537,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 136691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 164835,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 4667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 14692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 27648,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 44620,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 64335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 86292,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 110520,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 136673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 164817,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 4665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 4672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 4673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 14687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 14697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 14699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 27643,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 27653,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 27655,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 44614,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 44625,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 44629,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 64327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 64341,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 64346,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 86284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 86298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 86303,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 110512,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 110527,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 110535,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 136662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 136681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 136689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 164806,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 164825,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 164833,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 44610,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 64323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 86279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 110504,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 136654,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 164798,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    }
  ]
}